Previous studies have demonstrated that
tumor necrosis factor-alpha (TNF-α) in the red nucleus (RN) plays a facilitated role in the development of
neuropathic pain. Here, we further investigated the expression changes and roles of the downstream signaling molecules of the red nucleus TNF-α, including
nuclear factor-kappa B (NF-κB),
extracellular signal-regulated kinase (ERK),
p38 mitogen-activated protein kinase (MAPK) and
c-Jun N-terminal kinase (JNK), in the initiation and maintenance of
neuropathic pain induced by spared nerve injury (SNI). Immunohistochemistry demonstrated that increased expressions of NF-κB, phospho-ERK (p-ERK) and p-p38 MAPK were observed in the RN contralateral (but not ipsilateral) to the nerve injury side at 3 days after SNI compared with
sham-operated and normal rats, the up-regulations of NF-κB and p-ERK but not p-p38 MAPK remained at high levels till 14 days later. An elevated expression of p-JNK occurred at 14 days (but not 3 and 7 days) after SNI, which was later than those of NF-κB, p-ERK and p-p38 MAPK. The up-regulations of NF-κB, p-ERK, p-p38 MAPK and p-JNK all could be abolished by microinjection of anti-TNF-α antibody into the RN of rats with SNI. Microinjection of NF-κB inhibitor
PDTC, ERK inhibitor
PD98059,
p38 MAPK inhibitor
SB203580 but not JNK inhibitor
SP600125 into the RN contralateral to the nerve injury side at 3 days postinjury significantly alleviated SNI-induced
mechanical allodynia. In addition, microinjection of
PDTC,
PD98059 and
SP600125 but not
SB203580 into the RN at 14 days postinjury significantly alleviated SNI-induced
mechanical allodynia. These results suggest that the red nucleus TNF-α produces the algesic effect through activating NF-κB, ERK and
p38 MAPK in the early initiation stage but relying on the activation of NF-κB, ERK and JNK in the later maintenance stage of SNI-induced
neuropathic pain.